Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Vimentin anticorps

VIM Reactivité: Humain WB, IF Hôte: Poulet Polyclonal unconjugated
N° du produit ABIN361371
  • Antigène Voir toutes Vimentin (VIM) Anticorps
    Vimentin (VIM)
    Reactivité
    • 326
    • 126
    • 125
    • 60
    • 59
    • 44
    • 43
    • 37
    • 30
    • 22
    • 20
    • 14
    • 13
    • 8
    • 7
    • 6
    • 6
    • 4
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 187
    • 124
    • 9
    • 6
    • 4
    • 4
    • 2
    Poulet
    Clonalité
    • 198
    • 137
    Polyclonal
    Conjugué
    • 193
    • 19
    • 13
    • 13
    • 10
    • 7
    • 7
    • 7
    • 7
    • 7
    • 7
    • 7
    • 4
    • 4
    • 4
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    Cet anticorp Vimentin est non-conjugé
    Application
    • 275
    • 127
    • 99
    • 95
    • 95
    • 59
    • 46
    • 40
    • 39
    • 28
    • 23
    • 18
    • 8
    • 5
    • 4
    • 4
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunofluorescence (IF)
    Specificité
    Specific for the ~50kDa Vimentin protein. It is expected that it will work on other mammalian tissues.
     Réactivité croisée
    Boeuf (Vache), Humain, Souris, Rat (Rattus)
    Purification
    Total IgY fraction
    Immunogène
    Recombinant human vimentin purified from E. coli
    Top Product
    Discover our top product VIM Anticorps primaire
  • Indications d'application
    Recommended Dilution: WB: 1:1,000 IF: 1:500 Quality Control: Western blots performed on each lot.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    total IgY fraction in PBS + 10 mM Sodium azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C
  • Kirane, Toombs, Larsen, Ostapoff, Meshaw, Zaknoen, Brekken, Burrows: "Epithelial-mesenchymal transition increases tumor sensitivity to COX-2 inhibition by apricoxib." dans: Carcinogenesis, Vol. 33, Issue 9, pp. 1639-46, (2012) (PubMed).

    Kirane, Toombs, Ostapoff, Carbon, Zaknoen, Braunfeld, Schwarz, Burrows, Brekken: "Apricoxib, a novel inhibitor of COX-2, markedly improves standard therapy response in molecularly defined models of pancreatic cancer." dans: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 18, Issue 18, pp. 5031-42, (2012) (PubMed).

  • Antigène
    Vimentin (VIM)
    Autre désignation
    VIM (VIM Produits)
    Synonymes
    anticorps CTRCT30, anticorps cb28, anticorps vime, anticorps vim, anticorps vim1, anticorps vim2, anticorps VIM, anticorps Vimentin, anticorps vim4, anticorps vimentin, anticorps vimentin L homeolog, anticorps vimentin S homeolog, anticorps VIM, anticorps Vim, anticorps vim, anticorps vim.L, anticorps vim.S
    Sujet
    Vimentin is the major protein subunit of the 10nm or intermediate filaments (IFs) found in many kinds of mesenchymal and epithelial cells as well as developing neuronal and astrocytic precursor cells in the CNS. Vimentin is thought to be critically involved in lymphocyte adhesion and transmigration (Nieminen M et al. 2006). Copolymers are frequently formed between vimentin and other IFs, such as GFAP (in many kinds of astrocytes), desmin (in muscle cells) and neurofilament proteins (in developing neurons). Antibodies to vimentin are useful in studies of stem cells and generally to reveal the filamentous cytoskeleton. Recent studies suggest that vimentin affects prostate cancer cells motility and invasiveness (Zhao et al. 2008).
    Poids moléculaire
    '50 kDa
    ID gène
    7431
    UniProt
    P08670
    Pathways
    Caspase Cascade in Apoptosis
Vous êtes ici:
Support technique